# FMT for Multidrug Resistant Organism Reversal

> **NCT02312986** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 1 (actual)

## Conditions studied

- Infection With Multi-drug Resistant Organisms

## Interventions

- **BIOLOGICAL:** Fecal microbiota transplantation (FMT)

## Key facts

- **NCT ID:** NCT02312986
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312986, "FMT for Multidrug Resistant Organism Reversal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02312986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*